Environmental Medicine and Population Sciences, Department of Social Medicine, Graduate School of Medicine, Osaka University.
Cancer Control Center, Osaka International Cancer Institute.
J Epidemiol. 2024 Nov 5;34(11):505-514. doi: 10.2188/jea.JE20230280. Epub 2024 Jul 31.
In Japan, few studies have examined suicide risk for 5-year relative survival rates for cancer sites. Since 5-year relative survival rates differ by sex, we aim to examine suicide risk for patients with cancer separately for men and women.
We estimated the risk of suicide among patients with cancer by sex in Japan compared to the general population, using standardized mortality ratios (SMRs). Patients with cancer diagnosed between January 1, 1985-December 31, 2013 and registered in the Osaka Cancer Registry were followed for up to 10 years. The outcome was suicide death. In addition, cancer sites were classified into three prognosis groups based on 5-year relative survival rates: good (>70%), moderate (40-70%), poor (<40%).
Among 623,995 patients with cancer observed for 2,349,432 person-years, 1,210 patients died by suicide (867 men and 343 women). The SMRs were almost equal for men (1.66; 95% confidence interval [CI], 1.55-1.77) and women (1.65; 95% CI, 1.48-1.83). SMRs for cancer prognosis groups were 1.01 (95% CI, 0.84-1.22) for men and 1.47 (95% CI, 1.24-1.73) for women in the good group, 1.53 (95% CI, 1.39-1.68) for men and 1.74 (95% CI, 1.47-2.05) for women in the moderate group, and 2.54 (95% CI, 2.27-2.85) for men and 1.87 (95% CI, 1.43-2.46) for women in the poor group.
In this population, both sexes had higher suicide risk with poor prognosis, but the difference in SMRs between the good and poor groups was smaller for women than men.
在日本,很少有研究检查癌症部位的 5 年相对生存率的自杀风险。由于 5 年相对生存率因性别而异,我们旨在分别检查男性和女性癌症患者的自杀风险。
我们使用标准化死亡率比 (SMR) 来估计日本男性和女性癌症患者的自杀风险。1985 年 1 月 1 日至 2013 年 12 月 31 日期间诊断患有癌症并在大阪癌症登记处登记的患者被随访长达 10 年。结果是自杀死亡。此外,根据 5 年相对生存率将癌症部位分为三组预后组:良好 (>70%)、中等 (40-70%) 和差 (<40%)。
在观察了 623995 名癌症患者 2349432 人年期间,有 1210 名患者自杀身亡 (867 名男性和 343 名女性)。男性的 SMR 几乎相等 (1.66;95%CI,1.55-1.77)和女性 (1.65;95%CI,1.48-1.83)。男性良好预后组的 SMR 为 1.01(95%CI,0.84-1.22),女性为 1.47(95%CI,1.24-1.73),中等预后组男性为 1.53(95%CI,1.39-1.68),女性为 1.74(95%CI,1.47-2.05),不良预后组男性为 2.54(95%CI,2.27-2.85),女性为 1.87(95%CI,1.43-2.46)。
在该人群中,预后不良的男女自杀风险均较高,但女性良好和不良预后组之间 SMR 的差异小于男性。